Molbio Diagnostics Peer Comparison

NSE: MOLBIO | BSE: 544866

₹1,322.60

₹-112.20 (-7.82%)

As on 21-Oct-2026IST

Market cap

₹15,236 Cr

Revenue (TTM)

₹1,446 Cr

P/E Ratio

91.5

P/B Ratio

10.7

Div. Yield

0 %

Edit

	Molbio Diagnostics	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Market cap (₹ Cr)	15,236	33,140	30,799	28,294	13,936
Revenue (₹ Cr)	1,446	4,683	2,891	4,213	857
Net Profit (₹ Cr)	164.14	552.34	546.30	190.80	187.49
Net Margin (%)	11.28	11.55	18.23	4.49	21.32
RoE (%)	15.36	14.93	23.03	9.45	20.58
Price to Earnings	91.46	59.59	56.83	138.49	74.33
Price-To-Book	10.71	8.06	11.79	7.48	13.83

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Molbio Diagnostics	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Operating Revenue	1,445.69	4,410.27	2,762.91	3,904.60	814.20
Total Income	1,455.17	4,514.67	2,864.18	3,930.80	835.00
Total Expenditure	1,124.24	3,486.05	1,980.40	3,090.00	477.27
EBITDA	321.44	924.22	782.52	814.60	336.94
Depreciation	63.64	222.54	161.80	283.20	91.82
EBIT	257.80	701.68	620.71	531.40	245.11
Interest	33.47	90.05	22.80	215.10	33.23
Other Income	9.48	104.41	101.27	26.20	20.80
Exceptional Items	-0.49	-1.02	-30.09	-11.20	--
Profit before Tax	231.14	715.02	669.09	333.90	232.68
Provision for Tax	67.00	160.95	159.33	91.90	59.70
Profit after Tax	164.14	554.07	509.75	242.00	172.98

Liabilities (₹ Cr)

	Molbio Diagnostics	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Shareholder's Funds	1,169.34	3,961.57	2,508.14	2,247.40	957.15
Minority Interest	139.44	22.71	33.14	311.10	--
Non-Current Liabilities	230.74	1,277.95	66.56	3,833.90	426.03
Current Liabilities	557.36	627.13	450.62	1,238.90	123.86
Total Liabilities	2,115.31	5,905.00	3,139.97	7,690.70	1,507.05

Assets (₹ Cr)

	Molbio Diagnostics	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Non-Current Assets	712.03	4,214.44	1,491.97	6,693.90	1,185.15
Current Assets	1,384.84	1,674.92	1,566.49	937.40	321.90
Total Assets	2,115.31	5,905.00	3,139.97	7,690.70	1,507.05
Total Debt*	412.64	631.08	0.00	3,244.00	0.00
Net Current Assets	827.48	1,047.79	1,115.88	-301.50	198.04
Contingent Liabilities	168.74	100.01	16.76	81.10	0.13

Cashflow (₹ Cr)

	Molbio Diagnostics	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Cash From Operating Activities	50.39	714.39	635.61	510.80	270.59
Cash Flow from Investing Activities	-93.22	-1,089.11	-421.86	-1,451.70	-174.22
Cash from Financing Activities	276.07	271.85	-263.57	940.30	-69.49
Net Cash Inflow / Outflow	233.23	-102.87	-49.83	-0.60	26.88

Ratios

Profitability Ratios

	Molbio Diagnostics	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
ROCE (%)	19.79	19.38	29.56	11.51	30.28
ROE (%)	15.36	15.12	22.37	11.04	19.91
ROA (%)	9.35	10.43	17.92	3.64	12.44
EBIT Margin (%)	22.89	23.32	31.99	21.53	43.94
Net Margin (%)	11.28	12.27	17.80	6.16	20.72
Cash Profit Margin (%)	15.76	17.61	24.31	13.45	32.52

Growth Ratios

	Molbio Diagnostics	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Revenue Growth (%)	41.68	19.44	12.25	28.65	19.49
EBIT Growth (%)	22.68	6.57	12.01	1.93	22.71
Net Profit Growth (%)	18.45	15.11	3.56	-41.66	20.30
EPS Growth (%)	14.85	15.54	3.39	-37.22	19.99
Book Value Growth (%)	20.75	16.51	15.41	5.13	21.86

Valuation Ratios

	Molbio Diagnostics	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Price / Earnings	0.00	46.44	43.61	103.16	51.24
Price / Book Value	0.00	6.55	9.01	11.08	9.29
Dividend Yield (%)	--	0.05	1.56	0.00	0.23
EV/EBITDA	0.17	24.64	23.88	33.39	24.63
Market Cap (₹ Cr)	0.00	25,841.07	22,015.15	24,901.98	8,864.05

Solvency Ratios

	Molbio Diagnostics	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Debt to Equity	0.35	0.16	0.00	1.44	0.00
Short term debt to equity ratio	0.15	--	--	0.15	--
Current Ratio	2.48	2.67	3.48	0.76	2.60
Quick Ratio	1.68	2.54	3.38	0.68	2.56
Interest Coverage	7.91	8.94	30.35	2.55	8.00

Operating Efficiency Ratios

	Molbio Diagnostics	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Debtors to sales (%)	28.27	9.32	4.01	14.19	2.56
Asset Turnover	0.82	0.83	0.97	0.59	0.59
Receivable days	85.89	29.09	13.13	44.38	7.98
Inventory Days	111.74	6.05	5.28	7.52	2.20
Payable days	136.11	80.04	118.67	133.54	136.27
Cash Conversion Cycle	61.52	-44.90	-100.26	-81.64	-126.08